#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16394	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2605	775.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1999	1999	T	1054	T,G,C,A	1049,2,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16394	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2605	775.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1733	1733	C	1077	C,G	1076,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4023	864.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1891	1891	A	1085	A,G	1083,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4023	864.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2525	2525	C	976	C,T,G	970,4,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4023	864.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2599	2599	A	892	A,C,G	887,3,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4023	864.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3151	3151	C	999	C,G	998,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	G5V	NONSYN	13	15	GGT	535	537	GTT	150;150;150	G;T,A;T,G	150;148,2;149,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	E12K	NONSYN	34	36	GAA	556	558	AAA	175;174;177	A;A;A,G	175;174;176,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	F31L	NONSYN	91	93	TTT	613	615	TTG	208;211;211	T;T;G	207;211;211	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	646	648	CAA	230;231;228	C;A;A,G	230;231;227,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	S75P	NONSYN	223	225	TCC	745	747	CCT	212;217;213	C,T;C;T	211,1;217;213	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	V87A	NONSYN	259	261	GTA	781	783	GCA	192;193;193	G;C,T;A	192;192,1;193	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	V130L	NONSYN	388	390	GTC	910	912	CTC	285;284;287	C;T;C,G	285;284;286,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	R135C	NONSYN	403	405	CGC	925	927	TGT	288;286;285	T;G;T	288;286;285	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	T137A	NONSYN	409	411	ACG	931	933	GCG	286;287;286	G;C;G	285;287;286	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	973	975	AAG	283;283;285	A;A,C;G,A	283;282,1;284,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	976	978	AAT	281;279;280	A;A;T,G	281;279;279,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1174	1176	TTG	167;165;163	T;T,C,A;G	167;163,1,1;163	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1204	1206	AGC	151;152;154	A,G;G;C	150,1;152;154	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1273	1275	CTG	156;155;153	C;T,G;G	156;154,1;153	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1279	1281	TCC	149;149;149	T,A;C,A;C	148,1;148,1;149	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1294	1296	GTG	169;168;168	G;T;G	169;168;168	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2010	folP	852	852	93.78	folP.l15.c4.ctg.1	1935	129.2	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1345	1347	GCG	192;192;187	G;C;G	192;192;187	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5796	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3746	192.2	1	SNP	p	S91F	0	.	.	271	273	TCC	747	749	TCC	197;197;197	T,C;C;C	196,1;197;197	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5796	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3746	192.2	1	SNP	p	D95G	0	.	.	283	285	GAC	759	761	GAC	201;201;201	G,C;A;C	200,1;201;201	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5796	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3746	192.2	1	SNP	p	D95N	0	.	.	283	285	GAC	759	761	GAC	201;201;201	G,C;A;C	200,1;201;201	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	G27E	NONSYN	79	81	GGG	711	713	GAG	183;184;183	G,A;A;G	182,1;184;183	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	D79N	NONSYN	235	237	GAT	867	869	AAT	183;181;181	A;A,T;T	183;180,1;181	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	945	947	CAC	204;204;201	C;A;C,A	204;204;200,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	N110S	NONSYN	328	330	AAC	960	962	AGC	191;192;189	A;G;C	191;192;189	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	F178L	NONSYN	532	534	TTC	1164	1166	CTC	98;99;98	C;T;C,A	98;99;97,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	S183N	NONSYN	547	549	AGT	1179	1181	AAT	101;102;106	A,C;A,C;T	100,1;101,1;106	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	0	.	p	.	0	N203S	NONSYN	607	609	AAC	1239	1241	AGC	143;141;142	A;G,A;C,A	143;140,1;141,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1360	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1673	100.8	1	SNP	p	G45D	0	.	.	133	135	GGC	765	767	GGC	200;199;195	G,A;G;C,T	199,1;199;193,2	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1697	1699	ATC	261;257;259	A;T;C	261;257;259	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1850	1852	GCA	253;256;257	G,T;C,G;A,G	251,1;254,1;255,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	1	SNP	p	D86N	0	.	.	256	258	GAC	803	805	GAC	259;260;258	G,T,C;A,G,C;C,G	257,1,1;258,1,1;257,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	1	SNP	p	S87I	0	.	.	259	261	AGT	806	808	AGT	259;262;261	A;G;T	259;262;261	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	1	SNP	p	S87R	0	.	.	259	261	AGT	806	808	AGT	259;262;261	A;G;T	259;262;261	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	1	SNP	p	S87W	0	.	.	259	261	AGT	806	808	AGT	259;262;261	A;G;T	259;262;261	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5204	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3396	190.8	1	SNP	p	S88P	0	.	.	262	264	TCC	809	811	TCC	262;262;264	T,A;C,G;C,T	261,1;260,1;263,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4792	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3145	189.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1787	1789	GGC	256;260;262	G,A;G;C	255,1;260;262	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1496	1498	GCA	246;248;246	G,A;C;A	244,2;248;246	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1499	1501	ATC	243;244;242	A;T,A;C	243;242,2;242	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1511	1513	GTG	244;243;245	G;T;G	244;243;245	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1511	1513	GTG	244;243;245	G;T;G	244;243;245	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2015	2017	ACC	252;253;256	A;C;C	252;253;256	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2069	2071	GCG	265;266;264	G;C;G	265;266;264	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2069	2071	GCG	265;266;264	G;C;G	265;266;264	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2192	2194	GGT	270;269;272	G;G,T;T	270;268,1;272	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2201	2203	GGC	262;262;264	G,C;G;C,G	261,1;262;262,2	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2890	198.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2219	2221	CCG	268;267;266	C;C,T;G,C	268;266,1;265,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6172	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3562	215.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1868	1870	CTG	268;269;270	C;T,C;G	267;268,1;270	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2540	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2267	139.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	587	589	GGC	180;180;180	G,A;G,T;C,G	179,1;178,2;179,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2540	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2267	139.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	769	769	C	191	C	191	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	21;22;24	T;T;A	21;22;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	58;58;58	C;A;T	58;58;58	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	58;58;58	A;G;T	58;58;58	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	58;58;58	T;A;C	58;58;58	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	1;1;1	G;A;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;4;4	T;C;G	3;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	264	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	313	28.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1588	254.7	0	.	p	.	0	E41K	NONSYN	121	123	GAA	492	494	AAA	261;258;256	A;A,C;A	261;257,1;256	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1588	254.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1002	1002	T	268	T,A	267,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1588	254.7	1	SNP	p	G120K	0	.	.	358	360	GGT	729	731	GGT	278;279;281	G,A,C;G,A;T,G	275,1,2;278,1;279,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1588	254.7	1	SNP	p	A121N	0	.	.	361	363	GCC	732	734	GCC	284;289;294	G;C,T,A;C,G	284;286,2,1;292,2	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1588	254.7	1	SNP	p	A121D	0	.	.	361	363	GCC	732	734	GCC	284;289;294	G;C,T,A;C,G	284;286,2,1;292,2	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11300	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5201	270.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2142	2144	CAT	314;313;310	C;A,C;T,A,G	314;312,1;308,1,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1626	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1311	153.0	1	SNP	p	V57M	1	.	.	169	171	ATG	648	650	ATG	299;302;297	A;T;G,C	299;302;296,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
